Results 221 to 230 of about 907,642 (293)

Commentary: Catalysts of violence against women students: the role of the university, aggressors, and victims. [PDF]

open access: yesFront Psychol
Díaz-Sosa DM   +4 more
europepmc   +1 more source

Primary Psychoses Among Sentenced Prisoners in Finland

open access: yesCriminal Behaviour and Mental Health, EarlyView.
ABSTRACT Background Recent studies suggest an increased prevalence of primary psychotic disorders among sentenced prisoners in Finland. Exploring the extent and correlates of lifetime primary psychoses through high‐quality data is crucial for early identification and effective interventions within correctional settings.
Petra Laivonen   +2 more
wiley   +1 more source

Asynchronous LGBTQ+ Affirming Counseling Training With Early Career Counselors: A Mixed Methods Program Evaluation

open access: yesCounselor Education and Supervision, EarlyView.
ABSTRACT A growing body of research shows that training in LGBTQ+ affirming counseling (LGBTQ+ AC) positively impacts counselors’ perceived knowledge and skills in providing mental health services to LGBTQ+ communities. Existing program evaluations of LGBTQ+ AC, however, have primarily used synchronous delivery formats and cultural competency models ...
Amber L. Pope   +7 more
wiley   +1 more source

Violence against women and sexual reproductive health service use among Eritrean refugees in Ethiopia: a latent class analysis. [PDF]

open access: yesReprod Health
Zepro NB   +7 more
europepmc   +1 more source

Smiling warnings and silent complicity: An autoethnographic reflection on academic bullying and mobbing

open access: yesThe Canadian Journal of Chemical Engineering, EarlyView.
Abstract Academic bullying and mobbing are increasingly recognized as systemic features of contemporary higher education rather than isolated interpersonal conflicts. Academic bullying refers to sustained hostile behaviour, often enacted by individuals in positions of power, aimed at undermining a colleague's dignity, credibility, or career progression.
Daniele Marchisio
wiley   +1 more source

Optimal Dose and Safety of Intravenous Favipiravir in Hospitalized Patients With COVID‐19: A Dose‐Escalating, Randomized Controlled Phase Ib Study

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
AGILE (NCT04746183) is a Phase Ib/IIa platform, evaluating candidates to treat COVID‐19. Candidate Specific Trial 6 evaluated the safety and optimal dose of a novel intravenous formulation of favipiravir in a dose‐escalating, open‐label, randomized, controlled, Bayesian adaptive Phase Ib trial.
Tim Rowland   +48 more
wiley   +1 more source

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 Genotype and Use of 5‐HT3 Receptor Antagonists: 2026 Update

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
5‐hydroxytryptamine type 3 (5‐HT3) receptor antagonists are used to treat nausea and vomiting and in the prevention of chemotherapy‐induced, radiation‐induced, and postoperative nausea and vomiting. Most of the 5‐HT3 receptor antagonists (i.e., ondansetron, tropisetron, dolasetron, palonosetron, and ramosetron) are metabolized by CYP2D6, but the extent
Claire Moore   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy